Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Clinical trial NCT01598831 · COMPLETED
Trial details
- NCT number
- NCT01598831
- Sponsor
- Asahi Kasei Pharma America Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-29
- Primary completion
- 2018-04-05
- Enrollment
- 816
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.